SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-002675 to PALATIN TECHNOLOGIES INC (PTN)

PALATIN TECHNOLOGIES INC
Date: March 11, 2025 · CIK: 0000911216 · Accession: 0000000000-25-002675

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

Date
March 11, 2025
Author
Division of
Form
UPLOAD
Company
PALATIN TECHNOLOGIES INC

Letter

Re: Palatin Technologies, Inc. Draft Registration Statement on Form S-1 Submitted March 7, 2025 CIK No. 0000911216 Dear Carl Spana:

March 11, 2025

Carl Spana Chief Executive Officer Palatin Technologies, Inc. 4B Cedar Brook Drive Cranbury, NJ 08512

This is to advise you that we do not intend to review your registration statement.

We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tyler Howes at 202-551-3370 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Faith Charles, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 11, 2025

Carl Spana
Chief Executive Officer
Palatin Technologies, Inc.
4B Cedar Brook Drive
Cranbury, NJ 08512

 Re: Palatin Technologies, Inc.
 Draft Registration Statement on Form S-1
 Submitted March 7, 2025
 CIK No. 0000911216
Dear Carl Spana:

 This is to advise you that we do not intend to review your registration
statement.

 We request that you publicly file your registration statement no later
than 48 hours
prior to the requested effective date and time. Please refer to Rules 460 and
461 regarding
requests for acceleration. We remind you that the company and its management
are
responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review,
comments, action or absence of action by the staff.

 Please contact Tyler Howes at 202-551-3370 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Faith Charles, Esq.
</TEXT>
</DOCUMENT>